[HTML][HTML] Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy
Multiple sclerosis (MS) is a chronic inflammatory disease characterized by central nervous
system (CNS) lesions that can lead to severe physical or cognitive disability as well as …
system (CNS) lesions that can lead to severe physical or cognitive disability as well as …
The genetics of multiple sclerosis
A Didonna, JR Oksenberg - Exon Publications, 2017 - exonpublications.com
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system,
characterized by focal inflammation, demyelination, and axonal injury. The etiology of MS is …
characterized by focal inflammation, demyelination, and axonal injury. The etiology of MS is …
MHC class II risk alleles and amino acid residues in idiopathic membranous nephropathy
Z Cui, L Xie, F Chen, Z Pei, L Zhang, Z Qu… - Journal of the …, 2017 - journals.lww.com
Epitopes of phospholipase A2 receptor (PLA2R), the target antigen in idiopathic
membranous nephropathy (iMN), must be presented by the HLA–encoded MHC class II …
membranous nephropathy (iMN), must be presented by the HLA–encoded MHC class II …
Potential molecular mimicry between the human endogenous retrovirus W family envelope proteins and myelin proteins in multiple sclerosis
R Ramasamy, B Joseph, T Whittall - Immunology letters, 2017 - Elsevier
Multiple sclerosis is an autoimmune disease caused by the destruction of the myelin sheath
in the central nervous system. The major target molecules for the immune response are the …
in the central nervous system. The major target molecules for the immune response are the …
Gene variants of adhesion molecules act as modifiers of disease severity in MS
Objective: To assess the potential effect of variants in genes encoding molecules that are
implicated in leukocyte trafficking into the CNS on the clinical phenotype of multiple sclerosis …
implicated in leukocyte trafficking into the CNS on the clinical phenotype of multiple sclerosis …
HLA genotype as a marker of multiple sclerosis prognosis: A pilot study
AP Lysandropoulos, N Mavroudakis, M Pandolfo… - Journal of the …, 2017 - Elsevier
Objective The identification of a biomarker with prognostic value is an unmet need in
multiple sclerosis (MS). The objective of this study was to investigate a possible association …
multiple sclerosis (MS). The objective of this study was to investigate a possible association …
Human leucocyte antigen (HLA) class I and II typing in Belgian multiple sclerosis patients
AP Lysandropoulos, J Racapé, V Holovska… - Acta neurologica …, 2017 - Springer
This is one of the first studies to compare the frequencies of different human leucocyte
antigen (HLA) class I and II alleles and haplotype HLA-DRB1* 15-DQB1* 06 in a cohort of …
antigen (HLA) class I and II alleles and haplotype HLA-DRB1* 15-DQB1* 06 in a cohort of …
[HTML][HTML] Analysis of HLA-DRB1* 1501 in multiple sclerosis patients in Khuzestan Province, Iran
N Delfan, H Galehdari, SR Kazeminejad… - Zahedan Journal of …, 2017 - brieflands.com
Background: Multiple sclerosis (MS) is a demyelinating, autoimmune and
neurodegenerative disease of the central nervous system (CNS). The pathogenesis of this …
neurodegenerative disease of the central nervous system (CNS). The pathogenesis of this …
Multiple Sclerosis: Clinical Features, Immunopathogenesis, and Treatment
AA Lizarraga, WA Sheremata - Inflammatory Disorders of the Nervous …, 2017 - Springer
Classically, multiple sclerosis (MS) is characterized by relapses of neurological deficits
followed by remission. At present mechanisms of progressive aspects of the disease are …
followed by remission. At present mechanisms of progressive aspects of the disease are …